SIAG
ALIM

Signet Investment Advisory Group’s Alimera Sciences ALIM Stock Holding History

Signet Investment Advisory Group’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-500
Closed -$5K – 191
2018
Q4 		$5K Buy
+500
New +$7.29K 0.01% 183

Other funds holding ALIM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Signet Investment Advisory Group's ALIM Position: Q1 2019 in Review

Signet Investment Advisory Group sold out of Alimera Sciences (ALIM) in Q1 2019, closing a stake of 500 shares — an estimated $5K sold.

Signet Investment Advisory Group first reported a position in ALIM in Q4 2018 and held it in 1 quarter. The position peaked at $5K in Q4 2018. 39 funds tracked by Wall St. Rank hold ALIM as of Q1 2019.

  • Signet Investment Advisory Group reported no remaining Alimera Sciences position as of Q1 2019 after selling out during the quarter.
  • Signet Investment Advisory Group sold 500 Alimera Sciences shares in Q1 2019, an estimated $5K.
  • Signet Investment Advisory Group first reported a position in Alimera Sciences in Q4 2018 and held it in 1 quarter.
  • Signet Investment Advisory Group's Alimera Sciences position peaked at $5K in Q4 2018.
  • 39 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2019.

Based on Signet Investment Advisory Group's 13F filing for Q1 2019, filed 6 May 2019.